Powered by healthtechmovers.com
According to healthtechmovers.com, there are a few trending healthtech stocks that have recently received buy ratings and showing positive investor sentiment, as well as news headlines. With that said, the editors over at healthtechmovers.com, are adding the stocks below to their healthtech stock watchlist. That staff here at WallStreetSectors.com, will continue to monitor these healthtech companies to see if the momentum continues. WallStreetSectors.com is also looking into these tickers BMRN, PEPG, BLCO, COO, SAGE..
Recent BRBR Stock Price: $23.24
Summary: BellRing Brands, Inc. manufactures and sells nutrition products. The company offers protein shakes, other RTD beverages, powders and nutrition bars and supplements. It offers products under the Premier Protein, Dymatize and PowerBar, as well as Joint Juice and Supreme Protein brands. BellRing Brands, Inc. is based in St. Louis, Missouri.
Kenneth Zaslow analyst at BMO Capital reiterates coverage on BellRing Brands (BRBR) stock in the energy sector with a Buy rating and has set BRBR's stock price target at $ 34.
TipRanks.com reports that BellRing Brands currently has 8 analysts offering 12-month price targets on BRBR and the consensus is a Strong Buy rating with an average stock price target of $31.13. The most recent BRBR stock price we have is $23.24 and we are not making any BRBR forecasts at this time.
In addition, TradingView issued a n/a (possibly response change) rating for BRBR over the next month, Barchart.com has a Weak sell rating and Yahoo! Finance has a Neutral short-term outlook. Remember, securities are volatile, so please do your own research on BRBR. WallStreetSectors.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on BRBR, please click here >>
Avadel Pharmaceuticals, AVDL
Recent AVDL Stock Price: $8.22
Summary: Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Ami Fadia analyst at Needham reiterates coverage on Avadel Pharmaceuticals (AVDL) stock in the energy sector with a Buy rating and has set AVDL's stock price target at $ 9.
TipRanks.com reports that Avadel Pharmaceuticals currently has 5 analysts offering 12-month price targets on AVDL and the consensus is a Strong Buy rating with an average stock price target of $13.40. The most recent AVDL stock price we have is $8.22 and we are not making any AVDL forecasts at this time.
In addition, TradingView issued a n/a (possibly response change) rating for AVDL over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on AVDL. WallStreetSectors.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on AVDL, please click here >>
Imago BioSciences, IMGO
Recent IMGO Stock Price: $35.59
Summary: Imago BioSciences Inc. is a clinical stage biopharmaceutical company. It involved in discovering new medicines for the treatment of myeloproliferative neoplasms. Imago BioSciences Inc. is based in SOUTH SAN FRANCISCO, Calif.
Marc Frahm analyst at Cowen & Co. reiterates coverage on Imago BioSciences (IMGO) stock in the energy sector with a Hold rating and has set IMGO's stock price target at $ 36.
TipRanks.com reports that Imago BioSciences currently has 4 analysts offering 12-month price targets on IMGO and the consensus is a Hold rating with an average stock price target of $35.75. The most recent IMGO stock price we have is $35.59 and we are not making any IMGO forecasts at this time.
In addition, TradingView issued a n/a (possibly response change) rating for IMGO over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. Remember, securities are volatile, so please do your own research on IMGO. WallStreetSectors.com is not recommending this stock, we are just providing you with compiled information.
For the complete breakdown on IMGO, please click here >>
The editors at WallStreetSectors.com use a variety of research tools to generate our watchlists and research reports. One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. TipRanks.com tracks and measures the performance of over 50,000 financial experts. The TipRanks Star RankingTM is calculated based on expert success rate, average return and statistical significance. Get more from TipRanks.com here >>
WallStreetSectors.com keeps investors investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to WallStreetSectors.com.
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
==============================================================================